Showing results (231-240 of 281) with videos related to

Sort By:
Pageof 29
Drug Delivery|February 4, 2017
Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapyPreeti Kumari, Omkara Swami Muddineti, Sri Vishnu Kiran Rompicharla, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 21, 2017
Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer TreatmentVinit Raj, Amit Rai, Ashok K Singh, et al.
European Journal of Medicinal Chemistry|April 23, 2025
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validationAmbati Himaja, Ganesh Routholla, Tarun Patel, et al.
Journal of Biomolecular Structure & Dynamics|February 5, 2024
Discovery of thiazolidinedione-based pancreatic lipase inhibitors as anti-obesity agents: synthesis, <i>in silico</i> studies and pharmacological investigationsPrashant Dhiman, Nisha Yadav, Prashant S Auti, et al.
ACS Chemical Neuroscience|February 12, 2021
PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse ModelSravani Pulya, Ashutosh Mahale, Yamini Bobde, et al.
Nature Communications|October 27, 2011
Synapse microarray identification of small molecules that enhance synaptogenesisPeng Shi, Mark A Scott, Balaram Ghosh, et al.
American Journal of Respiratory Cell and Molecular Biology|February 8, 2012
Hypoxia response in asthma: differential modulation on inflammation and epithelial injuryTanveer Ahmad, Manish Kumar, Ulaganathan Mabalirajan, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2008
A genetic variation in inositol polyphosphate 4 phosphatase a enhances susceptibility to asthmaMamta Sharma, Jyotsna Batra, Ulaganathan Mabalirajan, et al.
Bioorganic Chemistry|October 30, 2021
Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft modelGanesh Routholla, Sravani Pulya, Tarun Patel, et al.
Biochemical Pharmacology|February 5, 2024
Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeuticsAvik Maji, Abhik Paul, Arnab Sarkar, et al.
Pageof 29